Aquestive Therapeutics Inc. (AQST) Tops Q3 EPS by 8c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q3 EPS of ($0.03), $0.08 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $13 million versus the consensus estimate of $11.51 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight